News By Tag
News By Location
Plenary Keynote Line Up at the Upcoming Molecular Medicine Tri-Conference
Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference
Positive Exposure: Celebrating the Beauty of Genetic Diversity
Rick Guidotti, Director, Positive Exposure
Overcoming Adversity When Life Throws Curve Balls
Dave Dravecky, Former Pitcher, San Francisco Giants and Cancer Survivor
Keynote Panel: Emerging Technologies & Industry Perspectives
Harry Glorikian, Founder & Managing Partner, Scientia Advisors LLC
Jeremy Bridge-Cook, Sr. VP of Assay Research and Development, Luminex Corporation
Gary Kennedy, Chairman and CEO, Remedy MD
Stephen Williams, CMO, SomaLogic
Over 400 speakers are scheduled to be part of the 19th Annual Molecular Medicine Tri-Conference agenda. Spanning five days, the upcoming Tri-Conference includes 2 partnering forums, 5 symposia, 18 short courses, and 12 core programs. For more information and a complete agenda, visit: http://www.triconference.com
Advance registration discounts are available until January 13, 2012.
To view the entire conference agenda and to register, please visit http://www.triconference.com
Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at firstname.lastname@example.org.
About Cambridge Healthtech Institute (http://www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.
# # #
Since 1992, Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.